WITHUS PHARMACEUTICAL Co.,LTD. (KOSDAQ:330350)
8,390.00
+250.00 (3.07%)
At close: Apr 1, 2026
KOSDAQ:330350 Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 17,390 | 17,893 | 9,173 | 9,012 | 13,831 |
Short-Term Investments | 1,000 | 1,000 | 1,000 | 10,500 | 2,500 |
Trading Asset Securities | 1,051 | - | 1,019 | 7,044 | 26,147 |
Cash & Short-Term Investments | 19,440 | 18,893 | 11,192 | 26,556 | 42,478 |
Cash Growth | 2.90% | 68.81% | -57.85% | -37.48% | 7.72% |
Accounts Receivable | 25,556 | 22,105 | 25,797 | 17,835 | 18,635 |
Other Receivables | 28.24 | 44.94 | 292.43 | 77.42 | 78.45 |
Receivables | 29,206 | 26,099 | 30,978 | 23,372 | 24,228 |
Inventory | 19,070 | 16,151 | 16,004 | 9,021 | 8,141 |
Prepaid Expenses | 21.18 | 24.01 | 43.49 | 317.7 | 1,523 |
Other Current Assets | 2.28 | 5.21 | 29.52 | 183.79 | 58.6 |
Total Current Assets | 67,740 | 61,173 | 58,247 | 59,451 | 76,427 |
Property, Plant & Equipment | 47,531 | 49,236 | 49,945 | 39,843 | 25,379 |
Long-Term Investments | 9,443 | 11,881 | 12,099 | 9,637 | 8,733 |
Other Intangible Assets | 4,540 | 4,573 | 2,532 | 2,528 | 1,548 |
Long-Term Accounts Receivable | 0 | -0 | -0 | 0 | -0 |
Long-Term Deferred Tax Assets | 2,150 | 1,471 | 1,198 | 1,549 | 1,380 |
Long-Term Deferred Charges | 5,120 | 6,266 | 6,315 | 5,893 | 5,035 |
Other Long-Term Assets | 120.56 | 87.95 | 443.21 | 493.87 | 476.13 |
Total Assets | 136,645 | 134,687 | 130,780 | 119,395 | 118,979 |
Accounts Payable | 4,928 | 3,620 | 7,190 | 3,447 | 2,435 |
Accrued Expenses | 1,199 | 1,191 | 1,066 | 1,037 | 1,154 |
Short-Term Debt | 16,000 | 19,000 | 11,424 | 12,519 | 12,839 |
Current Portion of Long-Term Debt | 2,333 | 2,333 | 3,333 | 2,000 | 1,000 |
Current Portion of Leases | 166.06 | 172.04 | 201.49 | 172.31 | 280.27 |
Current Income Taxes Payable | 47.52 | 298.63 | 243.82 | 645.94 | 761.3 |
Other Current Liabilities | 8,185 | 7,323 | 7,552 | 5,752 | 5,506 |
Total Current Liabilities | 32,859 | 33,938 | 31,011 | 25,572 | 23,975 |
Long-Term Debt | - | 2,333 | 4,667 | 6,600 | 8,700 |
Long-Term Leases | 224.95 | 226.39 | 375.14 | 175.65 | 285.61 |
Pension & Post-Retirement Benefits | 5,554 | 5,073 | 4,449 | 4,011 | 5,113 |
Other Long-Term Liabilities | 0 | 0 | 0 | 0 | - |
Total Liabilities | 38,638 | 41,571 | 40,502 | 36,359 | 38,074 |
Common Stock | 2,640 | 2,640 | 2,640 | 2,639 | 2,638 |
Additional Paid-In Capital | 15,109 | 15,109 | 15,109 | 14,997 | 14,948 |
Retained Earnings | 79,623 | 74,733 | 71,894 | 64,736 | 62,642 |
Treasury Stock | -35.66 | -35.66 | -35.66 | -35.66 | -35.66 |
Comprehensive Income & Other | 670.63 | 670.63 | 670.63 | 700.16 | 713.26 |
Shareholders' Equity | 98,007 | 93,117 | 90,278 | 83,036 | 80,905 |
Total Liabilities & Equity | 136,645 | 134,687 | 130,780 | 119,395 | 118,979 |
Total Debt | 18,724 | 24,065 | 20,001 | 21,467 | 23,105 |
Net Cash (Debt) | 716.07 | -5,172 | -8,809 | 5,089 | 19,373 |
Net Cash Growth | - | - | - | -73.73% | -12.80% |
Net Cash Per Share | 54.20 | -391.26 | -667.81 | 385.93 | 1467.59 |
Filing Date Shares Outstanding | 13.24 | 13.2 | 13.2 | 13.19 | 13.19 |
Total Common Shares Outstanding | 13.24 | 13.2 | 13.2 | 13.19 | 13.19 |
Working Capital | 34,881 | 27,235 | 27,236 | 33,878 | 52,452 |
Book Value Per Share | 7400.76 | 7054.46 | 6839.41 | 6295.23 | 6135.62 |
Tangible Book Value | 93,467 | 88,544 | 87,746 | 80,508 | 79,357 |
Tangible Book Value Per Share | 7057.94 | 6708.03 | 6647.62 | 6103.58 | 6018.20 |
Land | 6,985 | 6,985 | 6,985 | 6,596 | 6,238 |
Buildings | 34,896 | 34,896 | 34,896 | 10,057 | 9,657 |
Machinery | 22,662 | 21,821 | 18,050 | 14,250 | 13,519 |
Construction In Progress | 22.4 | 79.4 | 1,976 | 19,751 | 5,838 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.